Mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of HIV type 1 infection
- PMID: 15650424
- DOI: 10.1089/aid.2004.20.1314
Mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of HIV type 1 infection
Abstract
The aim of this study was to develop a computational model of HIV infection able to simulate the natural history of the disease and to test predictive parameters of disease progression. We describe the results of a numerical simulation of the cellular and humoral immune response to HIV-1 infection as an adaptive pathway in a "bit-string" space. A total of 650 simulations of the HIV-1 dynamics were performed with a modified version of the Celada-Seiden immune system model. Statistics are in agreement with epidemiological studies showing a log normal distribution for the time span between infection and the development of AIDS. As predictive parameters of disease progression we found that HIV-1 accumulates "bit" mutations mainly in the peptide sequences recognized by cytotoxic CD8 T cells, indicating that cell-mediated immunity plays a major role in viral control. The viral load set point was closely correlated with the time from infection to development of AIDS. Viral divergence from the viral quasispecies that was present at the beginning of infection in long-term nonprogressors (LTNP) was found to be similar to that found in rapid progressors at the time CD4 T cells drop below the critical value of 200 cells/microl. In contrast, the diversity indicated by the number of HIV strains present at the same time was higher for rapid and normal progressors compared to LTNP, suggesting that the early immune response can make the difference. This computational model may help to define the predictive parameters of HIV dynamics and disease progression, with potential applications in therapeutic and vaccine simulations.
Similar articles
-
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression.AIDS. 2014 Jun 1;28(9):1261-72. doi: 10.1097/QAD.0000000000000293. AIDS. 2014. PMID: 24732774
-
HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.AIDS. 2012 Jul 31;26(12):1517-22. doi: 10.1097/QAD.0b013e328354f539. AIDS. 2012. PMID: 22555160
-
Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.Virology. 1997 Nov 24;238(2):180-8. doi: 10.1006/viro.1997.8790. Virology. 1997. PMID: 9400591
-
Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.AIDS Rev. 2007 Jul-Sep;9(3):140-9. AIDS Rev. 2007. PMID: 17982939 Review.
-
Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.J Gen Virol. 2011 Feb;92(Pt 2):247-68. doi: 10.1099/vir.0.027102-0. Epub 2010 Nov 24. J Gen Virol. 2011. PMID: 21106806 Review.
Cited by
-
Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system.PLoS One. 2010 Apr 16;5(4):e9862. doi: 10.1371/journal.pone.0009862. PLoS One. 2010. PMID: 20419125 Free PMC article.
-
Criticality of timing for anti-HIV therapy initiation.PLoS One. 2010 Dec 23;5(12):e15294. doi: 10.1371/journal.pone.0015294. PLoS One. 2010. PMID: 21203461 Free PMC article.
-
Model refinement through high-performance computing: an agent-based HIV example.Immunome Res. 2010 Sep 27;6 Suppl 1(Suppl 1):S3. doi: 10.1186/1745-7580-6-S1-S3. Immunome Res. 2010. PMID: 20875154 Free PMC article.
-
Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis.Med Microbiol Immunol. 2010 Nov;199(4):323-32. doi: 10.1007/s00430-010-0167-9. Epub 2010 Aug 10. Med Microbiol Immunol. 2010. PMID: 20697741
-
From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling.Front Immunol. 2021 Sep 7;12:646972. doi: 10.3389/fimmu.2021.646972. eCollection 2021. Front Immunol. 2021. PMID: 34557181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials